Nanomedicine News

RSS

Superior Hybrid Gold Nanoparticle Cardiac Patch for Tissue Engineering

Because heart cells cannot multiply and cardiac muscles contain few stem cells, heart tissue is unable to repair itself after a heart attack. Now Tel Aviv University researchers are literally setting a new gold standard in cardiac tissue engineering.

1 Oct 2014

UCLA Re-Engineers Antibiotics to Enhance Activity Against Persister Cells

We face an urgent global health problem because scientists are not developing new antibiotics as fast as bacteria are developing antibiotic resistance.

30 Sep 2014

UNITAID Report on Tuberculosis Cites NanoLogix Detection Technology

NanoLogix Inc., an innovative biotechnology company in Northeastern Ohio announces that UNITAID, based in Geneva, Switzerland and hosted by the World Health Organization (WHO), on Friday published their Tuberculosis diagnostics technology and market landscape – 3rd edition. NanoLogix's sandwiched-membrane BNP rapid testing technology for tuberculosis is cited on pages 17 and 37 of the report.

From NanoLogix 30 Sep 2014

Researchers Develop New Technology to Inject RNA Carried by Lipidoid Nanoparticles

MIT engineers have devised a way to rapidly test hundreds of different drug-delivery vehicles in living animals, making it easier to discover promising new ways to deliver a class of drugs called biologics, which includes antibodies, peptides, RNA, and DNA, to human patients.

30 Sep 2014

Supersensitive Nanoprobe Sensor Enables Extremely Early Detection of Cancers

Extremely early detection of cancers and other diseases is on the horizon with a supersensitive nanodevice being developed at The University of Alabama in Huntsville (UAH) in collaboration with The Joint School of Nanoscience and Nanoengineering (JSNN) in Greensboro, NC.

30 Sep 2014

Researchers Open and Close Nanovesicles Using a Magnet

Chemists and physicists of Radboud University managed to open and close nanovesicles using a magnet. This process is repeatable and can be controlled remotely, allowing targeted drug transport in the body, for example.

26 Sep 2014

Swissmedic Approves Celgene’s ABRAXANE for Treatment of Metastatic Pancreatic and Breast Cancers

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation, today announced that Swissmedic, the regulatory authority for Switzerland, has granted approval for ABRAXANE® (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) as a treatment for metastatic pancreatic cancer (in combination with gemcitabine), and as a treatment for metastatic breast cancer.

25 Sep 2014

Liquidia to Present Unique Nanofabrication of Vaccine Formulations

Liquidia Technologies today announced it will highlight the rapid antigen and adjuvant formulation capabilities of its PRINT®(Particle Replication In Non-Wetting Templates) technology for the development of novel vaccines at the 4th International Conference on Vaccines and Vaccination, being held September 24-26, in Valencia, Spain.

From Liquidia Technologies, Inc. 24 Sep 2014

Cancer-Immune Cyberwar Nanocarriers

Research by Rice University scientists who are fighting a cyberwar against cancer finds that the immune system may be a clinician's most powerful ally.

24 Sep 2014

Novavax Reports Positive Data from Phase 1/2 Clinical Trial of H7N9 VLP with Matrix-M

Novavax, Inc. a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 1/2 clinical trial of its H7N9 Avian Influenza VLP Vaccine Candidate (H7N9 VLP) with proprietary adjuvant Matrix-M™.

From Novavax Inc. 24 Sep 2014